KPNA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.137700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.795200E-01
Normal-vs-Stage2
1.220010E-02
Normal-vs-Stage3
2.134800E-01
Normal-vs-Stage4
4.783600E-01
Stage1-vs-Stage2
3.315600E-01
Stage1-vs-Stage3
1.536590E-01
Stage1-vs-Stage4
9.452400E-01
Stage2-vs-Stage3
3.430800E-01
Stage2-vs-Stage4
1.658420E-01
Stage3-vs-Stage4
5.274400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.394100E-02
Normal-vs-AfricanAmerican
5.636400E-01
Normal-vs-Asian
2.338600E-01
Caucasian-vs-AfricanAmerican
1.021830E-01
Caucasian-vs-Asian
5.567900E-02
AfricanAmerican-vs-Asian
8.024300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.809510E-02
Normal-vs-Female
7.052100E-02
Male-vs-Female
2.031800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.733600E-01
Normal-vs-Age(41-60Yrs)
1.340570E-01
Normal-vs-Age(61-80Yrs)
1.830160E-02
Normal-vs-Age(81-100Yrs)
2.299400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.080400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.333600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.907640E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.060020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.884000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.866500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.581400E-01
Normal-vs-Daily Drinker
2.275400E-01
Normal-vs-Weekly Drinker
2.745600E-01
Normal-vs-Occasional Drinker
2.666600E-01
Normal-vs-Social Drinker
4.198200E-01
Non Drinker-vs-Daily Drinker
4.008600E-01
Non Drinker-vs-Weekly Drinker
7.860400E-01
Non Drinker-vs-Occasional Drinker
1.205430E-01
Non Drinker-vs-Social Drinker
1.843030E-01
Daily Drinker-vs-Weekly Drinker
2.987000E-01
Daily Drinker-vs-Occasional Drinker
4.894300E-02
Daily Drinker-vs-Social Drinker
1.045240E-01
Weekly Drinker-vs-Occasional Drinker
1.892020E-01
Weekly Drinker-vs-Social Drinker
2.413600E-01
Occasional Drinker-vs-Social Drinker
8.680400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.497600E-01
Normal-vs-Grade 2
6.459400E-01
Normal-vs-Grade 3
5.625400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.036770E-01
Grade 1-vs-Grade 3
2.210200E-01
Grade 1-vs-Grade 4
4.497600E-01
Grade 2-vs-Grade 3
8.013600E-01
Grade 2-vs-Grade 4
6.459400E-01
Grade 3-vs-Grade 4
5.625400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.280400E-02
Normal-vs-NonDiabetic
1.418270E-02
Diabetic-vs-NonDiabetic
7.735800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.173200E-01
Normal-vs-NoPancreatitis
2.711600E-02
Pancreatitis-vs-NoPancreatitis
2.904500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.044640E-01
Normal-vs-N1
1.124190E-02
N0-vs-N1
2.967000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.835400E-01
Normal-vs-TP53-NonMutant
2.975400E-01
TP53-Mutant-vs-TP53-NonMutant
4.082700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
